Corestreet Logo

Neurocrine Biosciences Inc (NBIX) Insider Trading

Total insider buys:
  • $39,032,821.44
Total insider sells:
  • $380,590,314.37
Most recent insider trade:
  • Feb. 13, 2025
Most active insider trader:
  • Kevin Charles Gorman
Trader NameDateTitleAmountPriceTypeTotal Value
Jan. 31, 2024CFO1,283$140.72Sell$180,543.76
Jan. 31, 2024CEO2,707$140.69Sell$380,847.83
Jan. 31, 2024Insider1,457$140.79Sell$205,131.03
Jan. 22, 2024Insider10,000$139.86Sell$1,398,600.00
Jan. 8, 2024CEO105,835$132.44Sell$14,016,787.40
Jan. 2, 2024Director11,044$131.47Sell$1,451,954.68
Jan. 2, 2024Insider75,000$131.47Sell$9,860,250.00
Dec. 22, 2023Insider10,000$126.74Sell$1,267,400.00
Dec. 12, 2023Insider13,925$120.30Sell$1,675,177.50
Dec. 8, 2023Insider300$120.10Sell$36,030.00
Dec. 6, 2023Insider20,830$119.86Sell$2,496,683.80
Dec. 1, 2023Director5,000$116.77Sell$583,850.00
Nov. 29, 2023Insider2,331$113.57Sell$264,731.67
Nov. 27, 2023Insider10,919$112.27Sell$1,225,876.13
Oct. 2, 2023Insider1,437$112.68Sell$161,921.16
Sept. 12, 2023Director5,000$115.02Sell$575,100.00
Sept. 1, 2023Director5,000$110.06Sell$550,300.00
Sept. 1, 2023Insider824$110.93Sell$91,406.32
Aug. 30, 2023Insider2,733$107.60Sell$294,070.80
Aug. 28, 2023Insider1,431$107.52Sell$153,861.12
Aug. 21, 2023CFO2,132$107.39Sell$228,955.48
Aug. 21, 2023CEO9,328$107.40Sell$1,001,827.20
Aug. 21, 2023Insider3,198$107.37Sell$343,369.26
May 1, 2023Director4,300$101.43Sell$436,149.00
May 1, 2023Insider11,397$103.89Sell$1,184,034.33
April 24, 2023Insider14,400$103.48Sell$1,490,112.00
April 21, 2023Director6,034$105.04Sell$633,811.36
April 19, 2023Director903$105.00Sell$94,815.00
Feb. 23, 2023Major Shareholder4,395,588$8.88Buy$39,032,821.44
Feb. 8, 2023CEO2,274$104.30Sell$237,178.20
Feb. 8, 2023Insider980$104.12Sell$102,037.60
Feb. 7, 2023CFO26,328$102.40Sell$2,695,987.20
Feb. 6, 2023CEO3,040$105.68Sell$321,267.20
Feb. 6, 2023Insider1,280$105.63Sell$135,206.40
Jan. 31, 2023CEO2,707$110.08Sell$297,986.56
Jan. 31, 2023Insider1,457$109.99Sell$160,255.43
Jan. 31, 2023CFO1,283$109.98Sell$141,104.34
Jan. 6, 2023Insider400$125.00Sell$50,000.00
Jan. 3, 2023Director30,000$118.86Sell$3,565,800.00
Nov. 30, 2022Insider50,000$125.90Sell$6,295,000.00
Nov. 10, 2022Insider100$125.36Sell$12,536.00
Nov. 8, 2022Insider24,593$125.33Sell$3,082,240.69
Nov. 3, 2022Insider4,518$125.02Sell$564,840.36
Nov. 1, 2022Insider10,000$120.09Sell$1,200,900.00
Oct. 31, 2022Director15,000$114.76Sell$1,721,400.00
Oct. 27, 2022Insider4,923$115.04Sell$566,341.92
Oct. 17, 2022Insider4,960$110.82Sell$549,667.20
Oct. 4, 2022Director5,000$110.54Sell$552,700.00
Oct. 3, 2022Insider1,437$106.59Sell$153,169.83
Aug. 12, 2022Insider21,533$105.95Sell$2,281,421.35
First«2 of 7»Last

  • Insiders are both buying and selling Neurocrine Biosciences Inc stock.

  • The insider traders at Neurocrine Biosciences Inc are: Kevin Charles Gorman, Gary A Lyons, Darin Lippoldt, Haig P Bozigian, Dimitri E Grigoriadis, Matt Abernethy, Christopher Flint Obrien, Eiry Roberts, Eric Benevich, Timothy P Coughlin, Kyle Gano, Julie Cooke, Ingrid Delaet, Malcolm Lloyd-Smith, William H Rastetter, Richard F Pops, David W Boyer, Stephen A Sherwin, W Thomas Mitchell, Timothy Coughlin, Corinne H Nevinny, Jude Onyia, Haig Bozigian, Dimitri Grigoriadis, Neurocrine Biosciences Inc, Shalini Sharp, Leslie V. Norwalk, Dimitri E. Grigoriadis, Gary A. Lyons, George J. Morrow, and Haig P. Bozigian

  • The most active insider trader at Neurocrine Biosciences Inc is Kevin Charles Gorman with 45 trades.

  • Kevin Charles Gorman has sold the most Neurocrine Biosciences Inc stock with a total value of $122,380,811.88.

  • Neurocrine Biosciences Inc has bought the most Neurocrine Biosciences Inc stock with a total value of $78,065,642.88.

  • The most recent insider trade for Neurocrine Biosciences Inc was on Feb. 13, 2025.

  • The single biggest insider buy for Neurocrine Biosciences Inc was from Neurocrine Biosciences Inc with a total value of $39,032,821.44 on Feb. 23, 2023.

  • The single biggest insider sell for Neurocrine Biosciences Inc was from Kevin Charles Gorman with a total value of $33,975,315.00 on Jan. 8, 2021.